Compare ROL & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ROL | WST |
|---|---|---|
| Founded | 1948 | 1923 |
| Country | United States | United States |
| Employees | 21946 | N/A |
| Industry | Diversified Commercial Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.5B | 17.9B |
| IPO Year | 1994 | 2004 |
| Metric | ROL | WST |
|---|---|---|
| Price | $54.04 | $237.74 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 7 |
| Target Price | $66.10 | ★ $319.43 |
| AVG Volume (30 Days) | ★ 2.7M | 720.7K |
| Earning Date | 04-22-2026 | 04-23-2026 |
| Dividend Yield | ★ 1.35% | 0.37% |
| EPS Growth | ★ 13.54 | 1.49 |
| EPS | 1.09 | ★ 6.79 |
| Revenue | $2,161,220,000.00 | ★ $2,886,900,000.00 |
| Revenue This Year | $10.37 | $6.73 |
| Revenue Next Year | $8.72 | $6.07 |
| P/E Ratio | $49.53 | ★ $35.17 |
| Revenue Growth | ★ 7.23 | 1.95 |
| 52 Week Low | $51.18 | $187.43 |
| 52 Week High | $66.14 | $322.34 |
| Indicator | ROL | WST |
|---|---|---|
| Relative Strength Index (RSI) | 28.85 | 45.29 |
| Support Level | N/A | $230.42 |
| Resistance Level | $58.38 | $251.73 |
| Average True Range (ATR) | 1.30 | 6.73 |
| MACD | -0.36 | -0.38 |
| Stochastic Oscillator | 1.77 | 33.95 |
Rollins is a global leader in route-based pest control services, with operations primarily in the United States and across North, Central, and South America, Europe, the Middle East, Africa, and Australia. Its portfolio of pest-control brands includes the prominent Orkin brand, a market leader in the US and Canada, with near-national coverage. It also has a portfolio of other brands, which it uses to reach customers through alternative sales channels. Residential pest and termite prevention accounts for the majority of Rollins' services, reflecting its ongoing focus on the US and Canadian markets.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.